Company intelligence / Profile preview

Outer Biosciences

Palo Alto, California, United Statesouterbio.com ↗

Ownership: Private
Employees: ~13
Development stage: Preclinical

Overview

Outer Biosciences develops novel bioactive compounds to improve human skin health using a proprietary platform that integrates advanced ex vivo human skin models with multimodal data analysis and machine learning. The company’s approach enables large-scale screening of compounds for efficacy and safety in anti-aging, inflammatory conditions, and general skincare. As of now, there are no reported clinical results or programs in clinical development.

Therapeutic areas: OtherDermatology
Modalities: Novel bioactives (bioactive compounds for skin health)Not small molecules or biologics in the traditional pharma sense; focus on bioactives for topical/skin use.
Industry: Biotech

Beyond the preview

Go deeper on Outer Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer Biosciences.

Explore the full profile